State Of Wisconsin Investment Board Krystal Biotech, Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

A detailed history of State Of Wisconsin Investment Board transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 23,068 shares of KRYS stock, worth $3.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,068

Previous 25,310 8.86%

Holding current value

$3.53 Million

Previous $4.65 Million 9.75%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$174.7 - $213.66 $391,677 - $479,025	-2,242 Reduced 8.86%	23,068 $4.19 Million
Q2 2024 Aug 14, 2024	BUY	$153.12 - $183.64 $1.39 Million - $1.67 Million	9,095 Added 56.09%	25,310 $4.65 Million
Q1 2024 May 14, 2024	BUY	$108.01 - $179.35 $142,465 - $236,562	1,319 Added 8.85%	16,215 $2.89 Million
Q4 2023 Feb 12, 2024	SELL	$96.0 - $128.29 $550,176 - $735,229	-5,731 Reduced 27.78%	14,896 $1.85 Million
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $423,189 - $507,858	3,900 Added 23.32%	20,627 $2.39 Million
Q2 2023 Aug 14, 2023	BUY	$78.48 - $130.32 $12,242 - $20,329	156 Added 0.94%	16,727 $1.96 Million
Q1 2023 May 15, 2023	SELL	$72.39 - $84.27 $70,073 - $81,573	-968 Reduced 5.52%	16,571 $1.33 Million
Q4 2022 Feb 14, 2023	SELL	$63.14 - $79.9 $13,133 - $16,619	-208 Reduced 1.17%	17,539 $1.39 Million
Q3 2022 Nov 14, 2022	SELL	$64.85 - $82.4 $72,178 - $91,711	-1,113 Reduced 5.9%	17,747 $1.24 Million
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $222,142 - $333,553	-4,540 Reduced 19.4%	18,860 $1.24 Million
Q1 2022 May 13, 2022	SELL	$51.99 - $72.11 $197,562 - $274,018	-3,800 Reduced 13.97%	23,400 $1.56 Million
Q4 2021 Feb 11, 2022	BUY	$39.81 - $88.24 $151,278 - $335,312	3,800 Added 16.24%	27,200 $1.9 Million
Q3 2021 Nov 12, 2021	BUY	$52.01 - $71.77 $234,045 - $322,965	4,500 Added 23.81%	23,400 $1.22 Million
Q4 2020 Feb 03, 2021	SELL	$40.64 - $61.38 $8,128 - $12,276	-200 Reduced 1.05%	18,900 $1.13 Million
Q3 2020 Nov 16, 2020	BUY	$37.76 - $48.49 $109,504 - $140,621	2,900 Added 17.9%	19,100 $822,000
Q1 2020 May 06, 2020	BUY	$35.02 - $65.64 $108,562 - $203,484	3,100 Added 23.66%	16,200 $700,000
Q3 2019 Nov 12, 2019	BUY	$34.72 - $51.3 $454,832 - $672,030	13,100 New	13,100 $455,000

Others Institutions Holding KRYS

# of Institutions

309

Shares Held

24.3M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $3.92B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Krystal Biotech, Inc. Transaction History